Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · IEX Real-Time Price · USD
2.710
-0.020 (-0.73%)
At close: Apr 18, 2024, 4:00 PM
2.600
-0.110 (-4.06%)
After-hours: Apr 18, 2024, 7:15 PM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $104.72 million as of April 18, 2024. Its market cap has increased by 15.21% in one year.
Market Cap
104.72M
Enterprise Value
-24.39M
1-Year Change
15.21%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $104.72M, a decrease of -81.92%. That is a compound annual growth rate of -43.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 101.20M | 2.74% |
Apr 16, 2024 | 98.50M | -4.18% |
Apr 15, 2024 | 102.80M | -15.88% |
Apr 12, 2024 | 122.20M | -5.71% |
Apr 11, 2024 | 129.60M | 3.10% |
Apr 10, 2024 | 125.70M | -1.87% |
Apr 9, 2024 | 128.10M | 1.59% |
Apr 8, 2024 | 126.10M | -1.79% |
Apr 5, 2024 | 128.40M | -10.08% |
Apr 4, 2024 | 142.80M | 26.04% |
Apr 3, 2024 | 113.30M | 22.89% |
Apr 2, 2024 | 92.20M | -3.35% |
Apr 1, 2024 | 95.40M | 3.02% |
Mar 28, 2024 | 92.60M | 2.09% |
Mar 27, 2024 | 90.70M | -2.89% |
Mar 26, 2024 | 93.40M | -0.43% |
Mar 25, 2024 | 93.80M | -6.57% |
Mar 22, 2024 | 100.40M | 7.04% |
Mar 21, 2024 | 93.80M | -1.68% |
Mar 20, 2024 | 95.40M | 2.69% |
Mar 19, 2024 | 92.90M | -0.96% |
Mar 18, 2024 | 93.80M | -1.68% |
Mar 15, 2024 | 95.40M | -1.45% |
Mar 14, 2024 | 96.80M | -1.53% |
Mar 13, 2024 | 98.30M | -1.21% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vivani Medical | 102.81M |
PDS Biotechnology | 100.65M |
KORU Medical Systems | 100.60M |
Anixa Biosciences | 100.48M |
Genelux | 100.34M |
Emergent BioSolutions | 99.97M |
IO Biotech | 99.76M |
TRACON Pharmaceuticals | 99.37M |